Zsolt Matula

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Multiple Myeloma

Respiratory Syndrome Coronavirus

Monoclonal Antibody

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Zsolt Matula, Gabriella Bekő, Viktória Király, Márton Gönczi, András Zóka, András Baráth, Ferenc Uher, István Vályi-Nagy
Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers. Vaccines 12 (1) (2023)
Zsolt Matula, Ferenc Uher, István Vályi-Nagy, Gábor Mikala
The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. International journal of molecular sciences 24 (6) (2023)
Zsolt Matula, Ferenc Uher, István Vályi-Nagy, Gábor Mikala
The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. International journal of molecular sciences 24 (6) (2023)
Zsolt Matula, Ferenc Uher, István Vályi-Nagy, Gábor Mikala
The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. International journal of molecular sciences 24 (6) (2023)
Zsolt Matula, Gabriella Bekő, Viktória Király, Márton Gönczi, András Zóka, András Baráth, Ferenc Uher, István Vályi-Nagy
Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers. Vaccines 12 (1) (2023)
Anita Marx, Magdolna Osváth, Bence Szikora, Orsolya Pipek, István Csabai, Akos Nagy, Csaba Bödör, Zsolt Matula, Ginette Nagy, András Bors, Ferenc Uher, Gábor Mikala, István Vályi-Nagy, Imre Kacskovics
Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study. PloS one 18 (5) (2023)
Zsolt Matula, Gabriella Bekő, Viktória Király, Márton Gönczi, András Zóka, András Baráth, Ferenc Uher, István Vályi-Nagy
Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers. Vaccines 12 (1) (2023)
Zsolt Matula, Márton Gönczi, Gabriella Bekő, Béla Kádár, Éva Ajzner, Ferenc Uher, István Vályi-Nagy
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy. Vaccines 10 (4) (2022)
Zsolt Matula, Gábor Mikala, Szilvia Lukácsi, János Matkó, Tamás Kovács, Éva Monostori, Ferenc Uher, István Vályi-Nagy
Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells. Cancers 13 (14) (2021)